NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hyundai Pharm (KO: 004310)

 
004310 Technical Analysis
4
As on 21st Nov 2025 004310 STOCK Price closed @ 3605.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3825.67 & Strong Sell for SHORT-TERM with Stoploss of 3879.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

004310STOCK Price

Open 3675.00 Change Price %
High 3680.00 1 Day -105.00 -2.83
Low 3595.00 1 Week -130.00 -3.48
Close 3605.00 1 Month -235.00 -6.12
Volume 76145 1 Year -165.00 -4.38
52 Week High 5820.00 | 52 Week Low 3000.00
 
KO Korea Most Active Stocks
093230 33.00 -49.23%
093230 33.00 -49.23%
068330 1852.00 15.53%
068330 1852.00 15.53%
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
009310 1378.00 30.00%
009310 1378.00 30.00%
084670 15740.00 29.98%
084670 15740.00 29.98%
000650 83000.00 29.89%
000650 83000.00 29.89%
000650 83000.00 29.89%
004060 393.00 29.70%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
093230 33.00 -49.23%
001745 3600.00 -46.27%
 
 
004310
Daily Charts
004310
Intraday Charts
Whats New @
Bazaartrend
004310
Free Analysis
 
004310 Important Levels Intraday
RESISTANCE3768.80
RESISTANCE3716.27
RESISTANCE3683.80
RESISTANCE3651.33
SUPPORT3558.68
SUPPORT3526.21
SUPPORT3493.74
SUPPORT3441.21
 
004310 Forecast November 2025
4th UP Forecast8152.72
3rd UP Forecast6694.24
2nd UP Forecast5792.72
1st UP Forecast4891.2
1st DOWN Forecast2318.8
2nd DOWN Forecast1417.28
3rd DOWN Forecast515.76
4th DOWN Forecast-942.72
 
004310 Weekly Forecast
4th UP Forecast3874.78
3rd UP Forecast3788.26
2nd UP Forecast3734.78
1st UP Forecast3681.30
1st DOWN Forecast3528.70
2nd DOWN Forecast3475.22
3rd DOWN Forecast3421.74
4th DOWN Forecast3335.22
 
004310 Forecast2025
4th UP Forecast10590.4
3rd UP Forecast8350.13
2nd UP Forecast6965.38
1st UP Forecast5580.63
1st DOWN Forecast1629.38
2nd DOWN Forecast244.63
3rd DOWN Forecast-1140.13
4th DOWN Forecast-3380.38
 
 
004310 Other Details
Segment EQ
Market Capital 167270400000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
004310 Address
004310
 
004310 Latest News
 
Your Comments and Response on Hyundai Pharm
 
004310 Business Profile
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antiviral, cardiovascular, central nervous system, contraceptive, depilatory, dermatological, diagnostic, digestive system, endocrine system, ENT, hemostatic, hormone therapy, musculo-skeletal system, ophthalmic, oral disease, respiratory, urogenital system, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial, arthritis, constipation, disinfectant, lip care, nutrition, and wound healing. It also develops products for the treatment of type 2 diabetes, bronchitis, senile disease, and osteoporosis. The company was founded in 1965 and is headquartered in Seoul, South Korea. Address: Hyundai Pharm Building, Seoul, South Korea, 06121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service